Patrick Serruys

Impact of periprocedural major adverse events on 10-year mortality after revascularisation

Kotoku N, Serruys P, Ninomiya K, Soo A, Masuda S, Kageyama S, Revaiah P, Mack M, Holmes DR, Morice M, Davierwala P, Mohr F, Milojevic M, Kappetein A, Garg S, Onuma Y

March 20, 2023 | 10.4244/EIJ-D-22-00681

Rocky II, Rambo II, and the ACURATE neo2

Serruys P, Elkoumy A, Garg S

January 23, 2023 | 10.4244/EIJ-E-22-00050

Pre-procedural planning of coronary revascularization by cardiac computed tomography: An expert consensus document of the Society of Cardiovascular Computed Tomography

Andreini D, Collet C, Leipsic J, Nieman K, Bittencurt M, De Mey J, Buls N, Onuma Y, Mushtaq S, Conte E, Bartorelli AL, Stefanini G, Sonck J, Knaapen P, Ghoshhajra B, Serruys P

December 2, 2022 | 10.4244/EIJ-E-22-00036

Transcatheter aortic valve implantation of a novel system for severe pure native aortic regurgitation in a patient with ascending aorta aneurysm

Wienemann H, Elzomor H, Kuhn E, Sinning J, Baldus S, Serruys P, Adam M

November 23, 2022 | 10.4244/EIJ-D-22-00747

Sirolimus-eluting stents with ultrathin struts versus everolimus-eluting stents for patients undergoing percutaneous coronary intervention: final three-year results of the TALENT trial

de Winter RJ, Zaman A, Hara H, Gao C, Ono M, Garg S, Smits P, Tonino P, Hofma S, Moreno R, Choudhury A, Petrov I, Cequier A, Colombo A, Kaul U, Onuma Y, Serruys P

August 19, 2022 | 10.4244/EIJ-D-21-00766

Ticagrelor monotherapy versus aspirin monotherapy at 12 months after percutaneous coronary intervention: a landmark analysis of the GLOBAL LEADERS trial

Ono M, Hara H, Kawashima H, Gao C, Wang R, Wykrzykowska JJ, Piek J, Garg S, Hamm C, Steg PG, Valgimigli M, Windecker S, Vranckx P, Onuma Y, Serruys P

August 5, 2022 | 10.4244/EIJ-D-21-00870

Definitions and Standardized Endpoints for Treatment of Coronary Bifurcations

Lunardi M, Louvard Y, Lefèvre T, Stankovic G, Burzotta F, Kassab G, Lassen J, Darremont O, Garg S, Koo B, Holm N, Johnson T, Pan M, Chatzizisis Y, Banning A, Chieffo A, Dudek D, Hildick-Smith D, Garot J, Henry T, Dangas G, Stone G, Krucoff M, Cutlip D, Mehran R, Wijns W, Sharif F, Serruys P, Onuma Y

May 18, 2022 | 10.4244/EIJ-E-22-00018

Impact of preprocedural biological markers on 10-year mortality in the SYNTAXES trial

Hara H, Kawashima H, Ono M, Takahashi K, Mack M, Holmes D, Morice M, Davierwala P, Mohr F, Thuijs D, Kappetein A, O'Leary N, van Klaveren D, Onuma Y, Serruys P

April 22, 2022 | 10.4244/EIJ-D-21-00415

A comparison of risk prediction models for patients with acute coronary syndromes

Hara H, O'Leary N, Ono M, Onuma Y, Serruys P

March 18, 2022 | 10.4244/EIJ-D-21-00536

EuroIntervention: the 200th issue

Serruys P

January 28, 2022 | 10.4244/EIJ-E-21-00004

Geographical variations in left main coronary artery revascularisation: a prespecified analysis of the EXCEL trial

Myat A, Hildick-Smith D, de Belder A, Trivedi U, Crowley A, Morice M, Kandzari D, Lembo N, Brown WM, Serruys P, Kappetein A, Sabik J, Stone G

January 28, 2022 | 10.4244/EIJ-D-21-00338

Reply: Composite endpoints in clinical trials - simplicity or perfection?

Hara H, Onuma Y, Serruys P

January 28, 2022 | 10.4244/EIJ-D-21-00440R

Optimal dual antiplatelet therapy duration for bioresorbable scaffolds: an individual patient data pooled analysis of the ABSORB trials

Azzalini L, Ellis S, Kereiakes D, Kimura T, Gao R, Onuma Y, Chevalier B, Dressler O, Crowley A, Zhou Z, Redfors B, Serruys P, Stone G

December 17, 2021 | 10.4244/EIJ-D-21-00263

Chronic haemodynamic performance of a biorestorative transcatheter heart valve in an ovine model

Serruys P, Kawashima H, Chang C, Modolo R, Wang R, de Winter RJ, Van Hauwermeiren H, El-Kurdi M, van den Bergh W, Cox M, Onuma Y, Flameng W, Soliman O

December 17, 2021 | 10.4244/EIJ-D-21-00386

Understanding the past, getting prepared for the future. (Going from in vivo to in vitro to in silico)

Serruys P, Elkoumy A, Soliman O

November 19, 2021 | 10.4244/EIJV17I10A136

Age and functional relevance of coronary stenosis: a post hoc analysis of the ADVISE II trial

Faria D, Lee JM, van de Hoef TP, Mejía-Rentería H, Echavarria-Pinto M, Baptista S, Cerrato E, Garcia-Garcia H, Davies J, Onuma Y, Samady H, Piek J, Serruys P, Lerman A, Escaned J

October 20, 2021 | 10.4244/EIJ-D-20-01163

Impact of the CABG SYNTAX score on all-cause death at 10 years: a SYNTAX Extended Survival (SYNTAXES) substudy

Takahashi K, Thuijs D, Hara H, Wang R, Mohr F, Morice M, Holmes D, Kappetein A, Head S, Onuma Y, Serruys P

May 16, 2021 | 10.4244/EIJ-D-20-00170

Statistical methods for composite endpoints

Hara H, van Klaveren D, Kogame N, Chichareon P, Modolo R, Tomaniak M, Ono M, Kawashima H, Takahashi K, Capodanno D, Onuma Y, Serruys P

April 2, 2021 | 10.4244/EIJ-D-19-00953

Impact of clinical and haemodynamic factors on coronary flow reserve and invasive coronary flow capacity in non-obstructed coronary arteries: a patient-level pooled analysis of the DEBATE and ILIAS studies

Stegehuis V, Wijntjens G, Bax M, Meuwissen M, Chamuleau S, Voskuil M, Koch K, Di Mario C, Vrints C, Haude M, Boersma E, Serruys P, Piek J, van de Hoef TP

April 2, 2021 | 10.4244/EIJ-D-19-00774

Five-year clinical outcomes of zotarolimus-eluting stents in coronary total occlusions

Kelbæk H, Yeh R, Engstrøm T, Neumann F, Serruys P, Windecker S, Belardi J, Qiao S, Xu B, Liu M, Silber S

March 19, 2021 | 10.4244/EIJ-D-19-00866

Patrick Serruys

Latest news